OMDA
Omada Health, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+27/100
Last price
20.73
▼ 0.22 (1.05%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
20.95
Day high
21.44
Day low
20.16
Volume
855.85K
Market cap
$1.27B
P/E (TTM)
86.38
52W range
10.28 – 26.92
Trailing performance
Returnvs SPY
1W
+7.02%
+5.1%
1M
-8.96%
-10.1%
3M
-9.79%
-14.3%
6M
+67.18%
+49.0%
YTD
+31.37%
+17.1%
1Y
-5.30%
-21.7%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on OMDA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-88.07K
Net selling
Buy transactions
39
372.59K shares
Sell transactions
41
460.66K shares
Net transactions
+80
Buys less sells
Sell : buy shares
1.2 : 1
Mixed
Insider-held shares
1.31M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | DUFFY SEAN P Chief Executive Officer |
SELL | 17.26K | $356.92K | Direct |
| Oct 1, 26 | DUFFY SEAN P Chief Executive Officer |
CONVERSION | 17.26K | $111.05K | Direct |
| Sep 10, 26 | COOK STEVEN L. Chief Financial Officer |
SELL | 6.80K | $148.64K | Direct |
| Sep 10, 26 | DUFFY SEAN P Chief Executive Officer |
SELL | 14.96K | $327.20K | Direct |
| Sep 10, 26 | SHAO WEI-LI President |
SELL | 4.04K | $88.21K | Direct |
| Sep 9, 26 | GRACEY CRAIG Officer |
SELL | 644 | $13.99K | Direct |
| Sep 1, 26 | DUFFY SEAN P Chief Executive Officer |
SELL | 21.57K | $509.46K | Direct |
| Sep 1, 26 | DUFFY SEAN P Chief Executive Officer |
CONVERSION | 21.57K | $150.66K | Direct |
| Aug 27, 26 | COOK STEVEN L. Chief Financial Officer |
SELL | 1.11K | $27.70K | Direct |
| Aug 27, 26 | COOK STEVEN L. Chief Financial Officer |
CONVERSION | 1.11K | $9.17K | Direct |
| Aug 12, 26 | SHAO WEI-LI President |
SELL | 8.87K | $221.80K | Direct |
| Aug 12, 26 | SHAO WEI-LI President |
SELL | 9.42K | $235.61K | Direct |
| Aug 11, 26 | COOK STEVEN L. Chief Financial Officer |
SELL | 16.84K | $421.55K | Direct |
| Aug 11, 26 | COOK STEVEN L. Chief Financial Officer |
CONVERSION | 16.84K | $138.75K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEAL ANNE |
Director | 20.62K | Stock Award(Grant) |
COOK STEVEN L. |
Chief Financial Officer | 173.91K | Sale |
DUFFY SEAN P |
Chief Executive Officer | 1.23M | Sale |
FETTER TREVOR |
Director | 135.62K | Stock Award(Grant) |
HILLEMAN JERYL L |
Director | 26.52K | Stock Award(Grant) |
JAIN SACHIN H. |
Director | 20.62K | Stock Award(Grant) |
KLAPSTEIN JULIE D |
Director | 21.96K | Stock Award(Grant) |
REVELATION ALPINE, L.L.C |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
ROOT JONATHAN D |
Director | 191.88K | Stock Award(Grant) |
SHAO WEI-LI |
President | 295.31K | Sale |
Fundamentals
Market cap$1.27B
Enterprise value$1.05B
Revenue (TTM)$309.76M
Gross profit$211.21M
EBITDA$5.43M
Net income$4.30M
EPS (TTM)$0.24
Free cash flow$11.92M
Total cash$221.71M
Total debt$0
Book value / share$4.17
Shares outstanding61.22M
Float51.03M
Short % of float12.44%
Dividend yield0.00%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E86.38
Forward P/E37.27
PEG ratio—
Price / sales—
Price / book4.97
EV / revenue3.38
EV / EBITDA192.84
Gross margin68.19%
Operating margin4.04%
Profit margin1.39%
Return on equity1.84%
Return on assets-0.09%
Debt / equity—
Current ratio3.91
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $260.21M | $169.80M | $122.78M | $89.19M | +53.2% |
| Operating revenue | $260.21M | $169.80M | $122.78M | $89.19M | +53.2% |
| Cost of revenue | $89.27M | $66.92M | $52.81M | $46.39M | +33.4% |
| Gross profit | $170.94M | $102.88M | $69.97M | $42.79M | +66.2% |
| Research & development | $40.68M | $35.92M | $33.74M | $26.17M | +13.3% |
| Selling, general & admin | $142.23M | $110.61M | $102.23M | $88.97M | +28.6% |
| Total operating expense | $182.91M | $146.53M | $135.97M | $115.14M | +24.8% |
| Operating income | -$11.97M | -$43.65M | -$66.00M | -$72.35M | +72.6% |
| Net interest income | $2.77M | -$3.70M | $1.07M | -$2.00M | +174.9% |
| Pre-tax income | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Net income to common | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Basic EPS | -0.35 | -0.85 | -1.41 | -1.52 | +58.6% |
| Diluted EPS | -0.35 | -0.85 | -1.41 | -1.52 | +58.6% |
| EBIT | -$10.24M | -$42.63M | -$62.81M | -$68.32M | +76.0% |
| EBITDA | -$4.75M | -$37.83M | -$58.36M | -$63.99M | +87.4% |
| Basic shares | 36.64M | 55.74M | 47.72M | 47.72M | -34.3% |
| Diluted shares | 36.64M | 55.74M | 47.72M | 47.72M | -34.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $222.04M | $76.39M | $115.64M | $168.12M | +190.7% |
| Cash & short-term investments | $222.04M | $76.39M | $115.64M | $168.12M | +190.7% |
| Accounts receivable | $13.56M | $9.48M | $7.58M | $4.93M | +43.0% |
| Inventory | $4.49M | $3.30M | $3.61M | $3.54M | +36.1% |
| Total current assets | $272.93M | $113.06M | $142.88M | $188.56M | +141.4% |
| Property, plant & equipment | $7.94M | $6.07M | $5.60M | $6.06M | +30.8% |
| Goodwill & intangibles | $15.65M | $17.50M | $19.51M | $21.55M | -10.6% |
| Total assets | $305.41M | $150.89M | $175.08M | $221.80M | +102.4% |
| Total current liabilities | $75.73M | $53.95M | $43.79M | $34.51M | +40.4% |
| Long-term debt | — | $29.77M | $29.38M | $28.89M | — |
| Total debt | $0 | $30.19M | $30.58M | $30.81M | -100.0% |
| Total liabilities | $75.73M | $535.29M | $76.16M | $66.19M | -85.9% |
| Retained earnings | -$456.74M | -$443.97M | -$396.83M | -$329.32M | -2.9% |
| Shareholder equity | $229.68M | -$384.40M | $98.92M | $155.60M | +159.7% |
| Working capital | $197.21M | $59.11M | $99.09M | $154.04M | +233.7% |
| Net tangible assets | $214.03M | -$401.91M | $79.41M | $134.05M | +153.3% |
| Shares issued | 58.43M | 55.74M | 55.74M | 55.74M | +4.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Depreciation & amortisation | $5.49M | $4.80M | $4.45M | $4.33M | +14.3% |
| Stock-based compensation | $12.96M | $9.42M | $8.74M | $6.65M | +37.5% |
| Change in working capital | $3.74M | -$6.57M | -$1.50M | -$9.14M | +156.9% |
| Operating cash flow | $18.25M | -$34.18M | -$49.74M | -$68.98M | +153.4% |
| Capital expenditure | -$5.83M | -$3.86M | -$2.92M | -$2.72M | -51.0% |
| Investing cash flow | -$5.83M | -$3.86M | -$2.92M | -$2.72M | -51.0% |
| Financing cash flow | $133.22M | -$1.21M | $179.00K | $16.32M | +11,119.4% |
| Free cash flow | $12.42M | -$38.04M | -$52.66M | -$71.70M | +132.6% |
| End cash position | $222.04M | $76.39M | $115.64M | $168.12M | +190.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $87.83M | $78.05M | $75.85M | $68.03M | $61.37M | +12.5% |
| Operating revenue | $87.83M | $78.05M | $75.85M | $68.03M | $61.37M | +12.5% |
| Cost of revenue | $24.05M | $29.36M | $22.18M | $22.96M | $21.07M | -18.1% |
| Gross profit | $63.79M | $48.69M | $53.66M | $45.07M | $40.31M | +31.0% |
| Research & development | $14.63M | $12.70M | $11.55M | $10.30M | $10.02M | +15.2% |
| Selling, general & admin | $45.61M | $40.78M | $38.83M | $37.28M | $34.63M | +11.9% |
| Total operating expense | $60.24M | $53.47M | $50.38M | $47.58M | $44.65M | +12.6% |
| Operating income | $3.55M | -$4.78M | $3.28M | -$2.51M | -$4.34M | +174.2% |
| Net interest income | $1.75M | $1.81M | $1.88M | $1.66M | -$231.00K | -3.6% |
| Pre-tax income | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Net income to common | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Basic EPS | 0.09 | -0.05 | 0.09 | -0.06 | -0.24 | +280.0% |
| Diluted EPS | 0.08 | -0.05 | 0.08 | -0.06 | -0.24 | +260.0% |
| EBIT | $5.31M | -$2.95M | $5.17M | -$2.83M | -$4.22M | +279.8% |
| EBITDA | $6.89M | -$1.44M | $6.62M | -$1.47M | -$2.87M | +577.1% |
| Basic shares | 59.69M | 58.92M | 58.06M | 57.66M | 21.97M | +1.3% |
| Diluted shares | 63.95M | 58.92M | 63.93M | 57.66M | 21.97M | +8.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $221.71M | $211.76M | $222.04M | $198.63M | $223.15M | — | +4.7% |
| Cash & short-term investments | $221.71M | $211.76M | $222.04M | $198.63M | $223.15M | — | +4.7% |
| Accounts receivable | $31.92M | $13.60M | $13.56M | $19.44M | $11.25M | — | +134.6% |
| Inventory | $4.12M | $3.83M | $4.49M | $3.15M | $3.47M | — | +7.5% |
| Total current assets | $294.91M | $269.43M | $272.93M | $254.90M | $271.11M | — | +9.5% |
| Property, plant & equipment | $9.10M | $8.46M | $7.94M | $7.54M | $6.55M | — | +7.6% |
| Goodwill & intangibles | $14.78M | $15.21M | $15.65M | $16.09M | $16.53M | — | -2.9% |
| Total assets | $328.22M | $302.80M | $305.41M | $287.47M | $302.97M | — | +8.4% |
| Total current liabilities | $75.48M | $68.68M | $75.73M | $70.12M | $57.99M | — | +9.9% |
| Long-term debt | — | — | — | — | $29.97M | $29.87M | — |
| Total debt | — | — | $0 | $0 | $29.97M | $30.08M | — |
| Total liabilities | $75.48M | $68.68M | $75.73M | $70.12M | $88.76M | — | +9.9% |
| Retained earnings | -$454.42M | -$459.71M | -$456.74M | -$461.90M | -$458.73M | — | +1.2% |
| Shareholder equity | $252.74M | $234.12M | $229.68M | $217.35M | $214.21M | — | +8.0% |
| Working capital | $219.43M | $200.75M | $197.21M | $184.78M | $213.12M | — | +9.3% |
| Net tangible assets | $237.96M | $218.90M | $214.03M | $201.25M | $197.68M | — | +8.7% |
| Shares issued | 60.61M | 59.24M | 58.43M | 57.89M | 57.32M | — | +2.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Depreciation & amortisation | $1.58M | $1.51M | $1.45M | $1.36M | $1.35M | +4.8% |
| Stock-based compensation | $5.63M | $4.21M | $3.75M | $3.54M | $2.83M | +33.8% |
| Change in working capital | -$9.88M | -$16.35M | $10.45M | $4.10M | $2.23M | +39.6% |
| Operating cash flow | $4.01M | -$11.83M | $21.38M | $10.13M | $2.86M | +133.9% |
| Capital expenditure | -$1.66M | -$1.56M | -$1.35M | -$1.99M | -$1.25M | -6.9% |
| Investing cash flow | -$1.66M | -$1.56M | -$1.35M | -$1.99M | -$1.25M | -6.9% |
| Financing cash flow | $7.60M | $3.12M | $3.38M | -$32.66M | $162.14M | +143.7% |
| Free cash flow | $2.34M | -$13.39M | $20.03M | $8.15M | $1.61M | +117.5% |
| End cash position | $221.71M | $211.76M | $222.04M | $198.63M | $223.15M | +4.7% |
Options analytics
Put / call volume
0.25
Call-heavy session
Put / call open interest
0.20
Positioning, not flow
Max pain
20.00
-3.5% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
95
Contracts, this expiry
Put volume
24
Contracts, this expiry
Heaviest call OI
25.00
935 contracts
Heaviest put OI
20.00
129 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.06 | 0.20 | +219.8% |
| Mar 2026 | -0.04 | 0.05 | +209.9% |
| Dec 2025 | 0.03 | 0.16 | +440.3% |
| Sep 2025 | -0.07 | 0.03 | +142.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.10 | 5 | $85.64M | +25.9% |
| Next quarter | 0.11 | 5 | $87.02M | +14.7% |
| Current year | 0.44 | 5 | $338.70M | +30.2% |
| Next year | 0.56 | 5 | $407.80M | +20.4% |
Analyst targets & ownership
Mean target$28.42
High target$35.00
Low target$22.00
Implied upside37.08%
Analyst count12
ConsensusBUY
Strong buy / Buy5 / 5
Hold2
Sell / Strong sell0 / 0
Held by insiders2.14%
Held by institutions87.07%
Institutions holding216
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
20.21
+2.57% from price
SMA 20
20.35
+1.88% from price
SMA 50
21.76
-4.75% from price
SMA 100
20.67
+0.27% from price
SMA 200
17.35
+19.51% from price
EMA 12
20.49
+1.19% from price
EMA 26
20.91
-0.86% from price
EMA 50
21.12
-1.86% from price
RSI (14)
48.5
Neutral
MACD (12,26,9)
-0.42
Hist 0.14
ATR (14)
0.94
4.52% of price
Realised vol 30D
54.1%
Annualised
Bollinger upper
21.68
20, 2σ
Bollinger lower
19.01
20, 2σ
50 / 200 cross
Golden
21.76 vs 17.35
Trend bias
Above 200
+19.51%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.14
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
54.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-59.1%
Peak to trough
Max drawdown 5Y
-59.1%
Peak to trough
ATR 14
0.94
4.52% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
7.47M
Prior 5.89M
Change vs prior
+26.9%
Shorts adding
% of float
12.44%
Elevated
% of shares out
12.20%
Against total outstanding
Days to cover
6.8
Crowded exit
Float
51.03M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 14, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Sep 11, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Sep 11, 26 | Needham | MAINTAINED | Buy | Buy |
| Sep 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 14, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 14, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Aug 12, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Aug 10, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 20, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 17, 26 | BTIG | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-16
Periodic Financial Reports
10-Q · 2026-05-08
Corporate Changes & Voting Matters
8-K · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-28
Periodic Financial Reports
10-K · 2026-03-06
Corporate Changes & Voting Matters
8-K · 2026-03-05
Headlines
Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
Motley Fool · 14d ago
Omada Health Insider Sold Shares Worth $327,197, According to a Recent SEC Filing
MT Newswires · 23d ago
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
GlobeNewswire · 27d ago
Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program
GlobeNewswire · 28d ago
Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares
Motley Fool · 28d ago
Here's Why Teladoc's Integrated Care Business Deserves More Attention
Zacks · 30d ago
Earnings To Watch: Omda AS (OSL:OMDA) Q2 2026 -- GF Value Sees 32% Upside
GuruFocus.com · 42d ago
Omada Health (OMDA) Q2 2026 Earnings Call Transcript
Motley Fool · 55d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.